Medical Doctor Program year 2022 Reported 2019–2022 Source: CMS Open Payments, 2026 publication

Nancy Wright

Pediatric Endocrinology Tallahassee, FL Medical Doctor

NPI 1134144272 CMS profile 594539

1804 Miccosukee Commons Dr, Suite 210, Tallahassee, FL 32308

Open in the dashboard

General payments

$19,961

169 records reported · program years 2019–2022

Research payments

$23,500

Paid to them · 24 records reported · program years 2019–2022

Ownership & investment interest

$0

None reported

Through program year 2022, Nancy Wright of Tallahassee, FL is reported in the CMS Open Payments database as having received $19,961 across 169 general payments and $23,500 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 91st percentile of Pediatric Endocrinology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

6 rows
Year Kind Relative to this record's peak year Amount Records
2022 General $1,993 57
2022 Research $3,125 4
2021 General $2,803 27
2021 Research $20,375 20
2020 General $10,038 48
2019 General $5,126 37

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Nancy Wright
  • Pediatric Endocrinology median
  • Middle half of Pediatric Endocrinology
  • National median

In program year 2025, general payments to Nancy Wright were reported at $0. Among 971 Pediatric Endocrinology profiles paid that year, the median was $293 and the middle half received between $106 and $1,640.

Show as a table
Year Nancy Wright Pediatric Endocrinology median Middle half National median
2019 $5,126 $196 $68–$845 $163
2020 $10,038 $124 $37–$722 $114
2021 $2,803 $134 $35–$691 $132
2022 $1,993 $177 $47–$726 $149
2023 $0 $236 $75–$887 $160
2024 $0 $259 $91–$979 $164
2025 $0 $293 $106–$1,640 $169

Breakdown

Who paid General payments · program years 2019–2022
  1. Arbor Pharmaceuticals, Inc. $13,958 21 payments
  2. AbbVie, Inc. $2,933 36 payments
  3. CGG Medical Inc $1,200 1 payment
  4. Xeris Pharmaceuticals, Inc. $301 16 payments
  5. Novo Nordisk Inc $280 16 payments
  6. TOLMAR Pharmaceuticals, Inc. $243 29 payments
  7. Ascendis Pharma, Inc. $161 7 payments
  8. Lilly USA, LLC $110 6 payments
  9. Dexcom, Inc. $93 5 payments
  10. Zealand Pharma US, Inc. $72 3 payments
  11. Other $607 29 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2022
  1. Honoraria $10,500 3 payments
  2. Travel and Lodging $2,920 10 payments
  3. Food and Beverage $2,743 129 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $2,250 2 payments
  5. Education $1,310 23 payments
  6. Consulting Fee $179 1 payment
  7. Debt forgiveness $59 1 payment
Products named General payments · program years 2019–2022
  1. Triptodur Pediatrics/Neonatology $9,426 11 payments
  2. Triptodur Pediatrics/Neonatology $4,532 10 payments
  3. LUPRON DEPOT Endocrinology $2,594 21 payments
  4. GVOKE PFS $301 16 payments
  5. FENSOLVI $228 23 payments
  6. Norditropin $209 12 payments
  7. SKYTROFA $161 7 payments
  8. LUPRON DEPOT Endocrinology $135 9 payments
  9. BAQSIMI $110 6 payments
  10. SYNTHROID $91 5 payments
  11. Other $888 49 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2022
  1. Arbor Pharmaceuticals, Inc. $23,500 24 payments

Records

193 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Pediatric Endocrinology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2022

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record